When is it not ethical to withhold treatment for rheumatoid arthritis?

Comment

Yusuf Yazici. Ann Rheum Dis. 2014 May.

. 2014 May;73(5):e25.

doi: 10.1136/annrheumdis-2013-205033. Epub 2013 Dec 24.

No abstract available

Keywords: DMARDs (biologic); DMARDs (synthetic); Rheumatoid Arthritis.

Comment in

Response to: 'When is it not ethical to withhold treatment for rheumatoid arthritis?' by Dr Yusuf Yazici.
Takeuchi T. Takeuchi T. Ann Rheum Dis. 2014 May;73(5):e26. doi: 10.1136/annrheumdis-2013-205042. Epub 2014 Feb 27. Ann Rheum Dis. 2014. PMID: 24577333 No abstract available.

Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.
Takeuchi T, Harigai M, Tanaka Y, Yamanaka H, Ishiguro N, Yamamoto K, Miyasaka N, Koike T, Kanazawa M, Oba T, Yoshinari T, Baker D; GO-MONO study group. Takeuchi T, et al. Ann Rheum Dis. 2013 Sep 1;72(9):1488-95. doi: 10.1136/annrheumdis-2012-201796. Epub 2012 Sep 14. Ann Rheum Dis. 2013. PMID: 22984173 Free PMC article. Clinical Trial.